Search

We determined pretreatment and acquired human immunodeficiency virus (HIV) drug resistance among children with HIV type 1 (HIV-1) in Jos, Nigeria. The majority (71%) of those who failed first-line antiretroviral therapy were on a nevirapine-containing regimen. The prevalence of pretreatment (48%) and acquired (76%) HIV drug resistance mutations was high in our study. Wider access to HIV drug resistance testing after treatment failure is necessary to optimize second-line treatment options among children with HIV in Nigeria. [ABSTRACT FROM AUTHOR]

Objective To compare oxygen supply options for health facilities in the Gambia and develop a decision-making algorithm for choosing oxygen delivery systems in Africa and the rest of the developing world. Methods Oxygen cylinders and concentrators were compared in terms of functionality and cost. Interviews with key informants using locally developed and adapted WHO instruments, operational assessments, cost-modelling and cost measurements were undertaken to determine whether oxygen cylinders or concentrators were the better choice. An algorithm and a software tool to guide the choice of oxygen delivery system were constructed. Findings In the Gambia, oxygen concentrators have significant advantages compared to cylinders where power is reliable; in other settings, cylinders are preferable as long as transporting them is feasible. Cylinder costs are greatly influenced by leakage, which is common, whereas concentrator costs are affected by the cost of power far more than by capital costs. Only two of 12 facilities in the Gambia were found suitable for concentrators; at the remaining 10 facilities, cylinders were the better option. Conclusion Neither concentrators nor cylinders are well suited to every situation, but a simple options assessment can determine which is better in each setting. Nationally this would result in improved supply and lower costs by comparison with conventional cylinders alone, although ensuring a reliable supply would remain a challenge. The decision algorithm and software tool designed for the Gambia could be applied in other developing countries. Objectif Comparer les options d'approvisionnement en oxygene qui s'offrent aux etablissements de soins de Gambie et developper un algorithme de prise de decisions pour guider le choix des systemes d'approvisionnement en oxygene en Afrique et dans le reste du monde en developpement. Methodes Les auteurs ont compare en termes de fonctionnalite et de cout les bouteilles et les concentrateurs d'oxygene. Ils ont interroge des informateurs cles en utilisant des instruments d'evaluation OMS mis au point et adaptes localement et realise des evaluations operationnelles, ainsi qu'une modelisation et des mesures des couts pour determiner le meilleur choix entre les bouteilles et les concentrateurs d'oxygene, lis ont elabore un algorithme et un outil logiciel pour guider la selection du systeme d'approvisionnement en oxygene. Resultats En Gambie, les concentrateurs d'oxygene presentent des avantages notables par rapport aux bouteilles lorsque I'alimentation electrique est fiable ; dans d'autres contextes, il est preferable de faire appel aux bouteilles dans la mesure ou leur transport est praticable. La presence de fuites, phenomene courant, influe fortement sur le cout des bouteilles, tandis que pour les concentrateurs, les couts energetiques sont de loin plus importants que les couts en capital. Sur les 12 etablissements gambiens, 2 seulement avaient interet d'apres l'etude a utiliser des concentrateurs ; pour les 10 autres, les bouteilles constituaient une meilleure option. Conclusion Ni les concentrateurs, ni les bouteilles ne conviennent a toutes les situations, mais une evaluation simple des options permet de determiner pour chaque contexte la meilleure solution. A l'echelle nationale, cette evaluation devrait conduire a une amelioration de I'approvisionnement et a une baisse des couts par rapport a la situation ou I'on utilise uniquement des bouteilles d'oxygene classiques, mais assurer un approvisionnement fiable devrait rester un defi. L'algorithme decisionnel et l'outil logiciel concus pour la Gambie devraient etre applicables dans d'autres pays en developpement. Objetivo Comparar las opciones de suministro de oxigeno para centros de salud en Gambia y desarrollar un algoritmo decisional para elegir los sistemas de suministro de oxigeno en Africa y en el resto del mundo en desarrollo. Metodos Se compararon la funcionalidad y el costo de las bombonas y los concentradores de oxigeno. Se Ilevaron a cabo entrevistas con informantes clave mediante instrumentos desarrollados localmente o adaptados a partir de otros de la OMS, evaluaciones operacionales, modelizaciones de costos y mediciones de costos a fin de determinar la mejor opcion entre las bombonas y los concentradores de oxigeno. Se desarrollo asi un algoritmo y un instrumento de software para fundamentar la eleccion dei sistema de suministro de oxigeno. Resultados En Gambia, los concentradores de oxigeno presentan ventajas importantes en comparacion con las bombonas alli donde el suministro electrico es fiable; en caso contrario, la opcion preferible son las bombonas, siempre y cuando sea factible transportarlas. El costo de las bombonas depende considerablemente de las fugas, un problema frecuente, mientras que el de los concentradores depende mucho mas del costo de la electricidad que de los gastos de infraestructura. Solo dos de los 12 centros de Gambia analizados reunian las condiciones idoneas para usar concentradores; en los otros diez centros, la mejor opcion eran las bombonas. Conclusion Ni los concentradores ni las bombonas son soluciones ideales para cualquier situacion, pero una simple evaluacion de esas dos opciones permite determinar cual es preferible en cada entorno. A nivel nacional, esa diferenciacion se traduciria en mejoras del suministro y menores costos en comparacion con el uso exclusivo de las bombonas convencionales, pero seguiria habiendo problemas para garantizar un suministro fiable. El algoritmo decisional y el instrumento de software concebidos para Gambia podrian aplicarse en otros paises en desarrollo., Introduction Acute respiratory infection, principally pneumonia, remains the leading cause of death in young children worldwide. (1-3) Case management of pneumonia is a key component of the WHO Integrated Management [...]

Background: There are few studies investigating the prevalence of latent tuberculosis infection (LTBI) in HIV-1-infected children on antiretroviral therapy (ART), but no data from Nigeria. This study determined the prevalence of LTBI in HIV-1-infected children on ART in our clinic. Knowing the prevalence and thus the burden of LTBI could help improve HIV care by enabling targeted isoniazid (INH) prophylaxis. Method: This observational study was carried out from September 2016 to August 2017 at the pediatric HIV clinic of the Jos University Teaching Hospital among HIV-1-infected children on ART, aged 6 months–15 years. LTBI was diagnosed using an interferon-gamma release assay, the ELISpot test, T-SPOT®.TB assay (Oxford Immunotec, Abingdon, UK) on freshly collected whole blood samples within 2 h. Children with a positive test were treated with INH after first excluding TB by chest X-ray and clinical evaluation. Results: Of the 90 children studied, 4 (4.4%) had LTBI diagnosed by ELISpot. Their median interquartile range (IQR) age was 10.4 years (7.9–12.5), the majority were male (54.4%) and most of them had originally received Bacille Calmette-Guérin (83/89, 93.3%). They had a median CD4 count of 694 cells/μL (472–1045). The median (IQR) CD4 count was higher in LTBI compared to non-LTBI children: 1286 cells/μL (953–1375) versus 683 cells/μL (465–1040), (P = 0.044). Conclusion: Although this study showed a very low prevalence of LTBI in our setting, it was still beneficial to the few children on ART identified with LTBI as it enabled treatment with INH. A larger study will be required to ascertain the actual burden of LTBI in such children in our setting. [ABSTRACT FROM AUTHOR]

Background: Interrupting anti-retroviral therapy (ART) for any number of reasons is an indication of a compromised adherence to ART. Several factors, including the pill burden from other drugs used in treating co-infections in children with human immunodeficiency virus (HIV), may influence ART adherence. The aim of this study was to identify the factors associated with ART interruption in HIV-1-infected children. Materials and Methods: A retrospective cohort study analysing data on 580 children consecutively enrolled on ART between February 2006 and December 2010 at the paediatric HIV clinic of Jos University Teaching Hospital (JUTH), Jos. Subjects were children aged 2 months -- 15 years diagnosed with HIV-1 infection and on first-line ART. Cotrimoxazole prophylaxis was usually commenced at diagnosis while awaiting ART commencement. Children diagnosed with tuberculosis (TB) were also placed on multiple individual anti-TB drugs. Statistical analysis used: A comparison of the data on children with and without ART interruption was made. Variables associated with ART interruption in a univariate analysis were fit in a multivariate logistic model to determine the factors that were associated with ART interruption. Results: Children on anti-TB drugs were twice more likely to interrupt ART compared to those who were not, (adjusted odds ratio, AOR = 1.84 (1.03-3.28); P = 0.04). But children on cotrimoxazole prophylaxis had a 57% reduction in the odds of interrupting ART compared to those who were not, (AOR = 0.43 (0.20- 0.93); P = 0.03). Conclusion: Children on ART and also taking multiple individual anti-TB drugs should be monitored closely for ART adherence. Cotrimoxazole prophylaxis should be encouraged in children diagnosed with HIV while awaiting ART commencement as this may prime them for a better ART adherence. [ABSTRACT FROM AUTHOR]

Failure to establish an appropriate balance between pro- and anti-inflammatory immune responses is believed to contribute to pathogenesis of severe malaria. To determine whether this balance is maintained by classical regulatory T cells (CD4+ FOXP3+ CD127-/low; Tregs) we compared cellular responses between Gambian children (n = 124) with severe Plasmodium falciparum malaria or uncomplicated malaria infections. Although no significant differences in Treg numbers or function were observed between the groups, Treg activity during acute disease was inversely correlated with malaria-specific memory responses detectable 28 days later. Thus, while Tregs may not regulate acute malarial inflammation, they may limit memory responses to levels that subsequently facilitate parasite clearance without causing immunopathology. Importantly, we identified a population of FOXP3-, CD45RO+ CD4+ T cells which coproduce IL-10 and IFN-c. These cells are more prevalent in children with uncomplicated malaria than in those with severe disease, suggesting that they may be the regulators of acute malarial inflammation. [ABSTRACT FROM AUTHOR]

Background: Mortality among Human Immunodeficiency Virus-1 (HIV-1) infected children initiated on Antiretroviral Therapy (ART) though on a decline still remains high in resource-limited countries. Identifying baseline factors that predict mortality could allow their possible modification in order to improve pediatric HIV care and reduce mortality. Methods: We conducted a retrospective cohort study analyzing data on 691 children, aged 2 months-15 years, diagnosed with HIV-1 infection and initiated on ART between July 2005 and March 2013 at the pediatric HIV clinic of Jos University Teaching Hospital. Lost to follow-up children were excluded from the analyses. A multivariate Cox proportional hazards model was fitted to identify predictors of mortality. Results: Median follow-up time for the 691 children initiated on ART was 4.4 years (interquartile range (IQR), 1.8-5.9) and at the end of 2752 person-years of follow-up, 32 (4.6%) had died and 659 (95.4%) survived. The mortality rate was 1.0 per 100 child-years of follow-up period. The median age of those who died was about two times lower than that of survivors [1.7 years (IQR, 0.6-3.6) versus 3.9 years (IQR, 3.9 - 10.3), p<0.001]. On unadjusted Cox regression, the risk of dying was about three and half times more in children <5 years of age compared to those >5 years (p=0.02) Multivariate modeling identified age as the main predictor of death with mortality decreasing by 24% for every 1 year increase in age (Adjusted Hazard Ratio (AHR)=0.76 [0.62-0.94], p=0.013. Conclusion: The lower mortality rate for our study suggests that even in RLCs, mortality rates could be reduced given a good standard of care. Early initiation of ART in younger children with close monitoring during follow-up could further reduce mortality.